May 15, 2024
Guochun Jiang, PhD, assistant professor of biochemistry and biophysics and member of the UNC HIV Cure Center, received an R01 grant from the National Institute of Mental Health for his project “Defining the HIV reservoir and latency mechanism in human brain myeloid cells” which is funded for five years and $4.6 million.
February 13, 2024
Cynthia L. Gay, MD, MPH, associate professor of infectious diseases, and David Margolis, MD, the Sarah Kenan Distinguished Professor of Medicine, Microbiology & Immunology, and Epidemiology in the UNC School of Medicine, published results of a clinical trial showing that vorinostat and immunotherapy may modestly shrink the latent HIV reservoir.
December 15, 2023
UNC-Chapel Hill was recently named a National HIV Residency Pathway Consortium Site and awarded a year-long, $68,000 grant to support its efforts in training family medicine and internal medicine residents in caring for people with HIV. UNC’s site Investigators, Rick Moore, MD, and Louise Rambo King, MD, have a storied history of caring for patients with HIV.
November 14, 2023
Anne Drapkin Lyerly, MD, professor of Social Medicine and research professor in Obstetrics and Gynecology at the UNC School of Medicine, talks HIV research in pregnant and lactating women in Px Pulse podcast.
August 10, 2023
UNC School of Medicine researchers Angela Wahl, PhD, Balfour Sartor MD, J. Victor Garcia, PhD, and colleagues created a germ-free mouse model to evaluate the role of the microbiome in the infection, replication, and pathogenesis of HIV and Epstein-Barr virus, the virus that can cause mononucleosis and other serious diseases.
February 9, 2023
Rahima Benhabbour, PhD, MSc, associate professor of Biomedical Engineering, led a successful effort to create an injectable implant that can release effective HIV PrEP medications into the body for six months in non-human primates.
January 30, 2023
This research, led by UNC School of Medicine scientists Laura Kincer, Sarah Joseph, PhD, and Ron Swanstrom, PhD, with international collaborators, shows that in addition to HIV’s ability to lay dormant in the blood/lymphoid system, the virus may also lay dormant in the central nervous system, delineating another challenge in creating a cure.
January 30, 2023
Carla Chibwesha, MD, MSc, an associate professor of obstetrics and gynecology in the University of North Carolina’s Division of Global Women’s Health and the UNC Lineberger Comprehensive Cancer Center, will work with researchers at Weill Cornell Medicine and Moffitt Cancer Center develop trials to be conducted at clinical sites in Kenya, Uganda and Botswana.
August 17, 2021
The National Institutes of Health will award $53 million annually to 10 research organizations over the next five years to continue working toward curative therapies for HIV. The Collaboratory of AIDS Researchers for Eradication (CARE), led at the UNC HIV Cure Center by David Margolis, MD, is one of two programs to have received funds for all three five-year grant cycles since 2011.
August 11, 2021
Tonia Poteat, PhD, CHER Core Faculty, and colleagues have published research on transgender women's intervention preferences for addressing HIV vulnerability determinants. Results from the study interviews are grouped into themes, with a variety of messages related to support that does not center HIV.
July 8, 2021
Ed Browne, PhD, assistant professor of medicine, is the principal investigator of a $4-million, 5-year study of the role of cannabis use in HIV latency – one of the main barriers toward curing people with the infection.
May 5, 2021
UNC-Chapel Hill and Duke researchers promote better health through gamification. The study was co-led by Lisa Hightow-Weidman, MD, MPH, at the UNC School of Medicine, and Kate Meussig, Phd, at the UNC Gillings School of Global Public Health.